0
0

Synthetic Opioid Danger Awareness Act

4/17/2024, 11:45 PM

Summary of Bill HR 2364

Bill 117 HR 2364, also known as the Synthetic Opioid Danger Awareness Act, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to increase awareness of the dangers of synthetic opioids, such as fentanyl, and to provide resources for law enforcement agencies to combat the opioid crisis.

The bill includes provisions for the creation of a public awareness campaign to educate the public about the risks associated with synthetic opioids. This campaign would include information on the signs of opioid overdose and resources for individuals struggling with addiction.

Additionally, the bill allocates funding for training programs for law enforcement officers on how to safely handle synthetic opioids and respond to overdose situations. This training would help officers better understand the risks associated with these drugs and how to protect themselves and others when encountering them in the field. Overall, the Synthetic Opioid Danger Awareness Act aims to address the growing crisis of synthetic opioid use in the United States by increasing awareness and providing resources for law enforcement. It is a bipartisan effort to combat the opioid epidemic and protect communities from the dangers of these powerful drugs.

Current Status of Bill HR 2364

Bill HR 2364 is currently in the status of Bill Introduced since April 5, 2021. Bill HR 2364 was introduced during Congress 117 and was introduced to the House on April 5, 2021.  Bill HR 2364's most recent activity was Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of December 9, 2021

Bipartisan Support of Bill HR 2364

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2364

Primary Policy Focus

Health

Comments